Vericel Corporation Revenue per Employee (VCEL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vericel Corporation  (NASDAQ: VCEL)
 

Vericel's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 30.09% in the first quarter 2026, year on year to cumulative value of $292 million, Vericel's revenue per employee grew on a trailing twelve months basis to $ 733,884, this marks a new company high.
Within the Healthcare sector Employees of 78 other companies have achieved higher revenue per employee. While Vericel's total ranking has deteriorated compared to the previous quarter from 720 to 784. Vericel has 398 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VCEL Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Revenue Change 30.09 % 23.27 % 16.58 % 20.09 % 2.57 %
Sales per Employee (TTM) $ 733,884 694,118 650,043 625,927 599,349
VCEL's Total Ranking # 784 # 720 # 1086 # 351 # 859
Seq. Revenue Change -26.36 % 37.65 % 6.74 % 20.23 % -30.22 %

VCEL Company Profile >> Back to VCEL Efficiency Comparisons >> Compare VCEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 79
Overall Market # 784

Revenue per Employee Statistics
High Average Low
$ 733,884 $ 357,183 $ 124,714
(Mar 31 2026)   (Mar 31 2017)



Financial Statements
Vericel's Revenue MRQ $ 68 Millions Visit VCEL's Income Statement
Vericel's Revenues TTM $ 292 Millions Visit VCEL's aggregate revenue growth
What are VCEL's Sales? Visit VCEL's Sales by Segment




Other Ratios
Vericel's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VCEL's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VCEL's Competitors
Revenue per Employee for VCEL's Suppliers
Revenue per Employee for VCEL's Customers

You may also want to know
VCEL's Sales Growth Rates VCEL's Pe Price to earnings ratio VCEL's Receivables Turnover Ratio VCEL's Stock Quote
VCEL's Net Income Growth Rates VCEL's Ps Price to Sales ratio VCEL's Sales per Employee VCEL's Asset Turnover Ratio
VCEL's Net Margin VCEL's Pb Price to Book ratio VCEL's Financial Strength Ratios VCEL's Dividend Payout Ratio
Date modified: 2026-08-30T14:42:16+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million 8 
Sanara Medtech Inc   989,563.23 $ 106.873  Million 108 
Assembly Biosciences Inc   973,931.51 $ 71.097  Million 73 
Hims and Hers Health Inc   970,301.39 $ 2,369.476  Million 2,442 
Regeneron Pharmaceuticals Inc   968,176.51 $ 14,919.600  Million 15,410 
Ani Pharmaceuticals Inc  952,274.23 $ 923.706  Million 970 
Integrated Biopharma Inc  944,820.00 $ 47.241  Million 50 
Evolus Inc   905,236.53 $ 302.349  Million 334 
Pacira Biosciences inc   886,446.32 $ 734.864  Million 829 
Keenova Therapeutics Plc  883,125.00 $ 1,413.000  Million 1,600 
Nektar Therapeutics  883,063.49 $ 55.633  Million 63 
Merck and Co Inc   876,906.67 $ 65,768.000  Million 75,000 
Arrowhead Pharmaceuticals Inc   874,836.85 $ 622.009  Million 711 
Ardelyx inc   874,599.18 $ 427.679  Million 489 
Lifevantage Corp  868,242.15 $ 193.618  Million 223 
Prothena Corporation Public Limited Company  864,776.12 $ 57.940  Million 67 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.